NCIt definition : A novel dual inhibitor targeting human vascular endothelial growth factor receptors
(VEGFRs) and fibroblast growth factor receptors (FGFRs) with antiangiogenic activity.
Lucitanib inhibits VEGFR-1, -2, -3 and FGFR-1, -2 kinases in the nM range, which may
result in the inhibition of tumor angiogenesis and tumor cell proliferation, and the
induction of tumor cell death. Both VEGFRs and FGFRs belong to the family of receptor
tyrosine kinases that may be upregulated in various tumor cell types.;
UNII : PP449XA4BH;
InChIKey : CUDVHEFYRIWYQD-UHFFFAOYSA-N;
CAS number : 1058137-23-7; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1058137-23-7
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;